-

MEDIA ALERT: Element Biosciences to Unveil its AVITI™ System at “Sequencing Reimagined” Virtual Event on March 14, 2022

SAN DIEGO--(BUSINESS WIRE)--Element Biosciences Inc., developer of a new and disruptive DNA sequencing platform, is hosting a virtual event to launch its AVITI benchtop sequencer that offers unprecedented performance, cost and flexibility. The virtual event will occur on March 14 at 9 a.m. PT/5 p.m. CET and will highlight AVITI’s product specs, data quality, and pricing information.

Early AVITI adopters, key executives from Element Biosciences, J.P. Morgan Chase & Co. and industry-leading partner companies are slated to speak at the 3-hour event. Topics will include early adopter and industry-leader experiences with AVITI, and application notes and testimonials from NGS workflow partners including library prep and data analysis. Companies like DeepVariant, Fabric Genomics, Jumpcode Genomics and Sentieon will share their firsthand experiences with the data generated from AVITI. Element will also share data from the integration of recently acquired Loop Genomics’ long-read technology with AVITI’s short read sequencing.

View the full agenda and register to attend the virtual event: https://registration.elementbiosciences.com/

About Element Biosciences, Inc.

Element Biosciences is a multi-disciplinary life science company currently focused on developing disruptive DNA sequencing technology for research and diagnostic markets. Through innovating every fundamental element of a sequencing system, Element will empower customers with affordable high-quality data and an improved user experience, which in turn will accelerate scientific discoveries and broaden the use of genomic medicine. To learn more about Element, please visit www.elementbiosciences.com

Contacts

Valerie Enes
(408) 497-8568
valerie@teamseismic.com

Industry:

Element Biosciences Inc.

Release Summary
Element Biosciences to Unveil its AVITI™ System at “Sequencing Reimagined” Virtual Event on March 14, 2022
Release Versions
English

Contacts

Valerie Enes
(408) 497-8568
valerie@teamseismic.com

More News From Element Biosciences Inc.

Element Biosciences Announces First Customer Shipments and New Offerings for AVITI™ System

SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc., developer of the Element AVITI™ System, a new and disruptive DNA sequencing platform, today announced it has shipped multiple AVITI systems to its first set of customers. Additionally, Element is introducing new volume-based pricing, launching ElemBio Capital Solutions™ for financing and leasing options, and announcing the upcoming launch of its new AVITI 150-Cycle Sequencing Kit to ship Q4 2022. This is all to meet rapidly growing customer...

Element Biosciences Debuts New Headquarters in San Diego

SAN DIEGO--(BUSINESS WIRE)--Element Biosciences Inc., developer of the Element AVITI™ System, a new and disruptive DNA sequencing platform, today announced that it has moved its headquarters to the Alexandria Tech Center located on the 37-acre, 14-building campus in the Sorrento Mesa life science hub of San Diego, California. Alexandria Tech Center includes amenities such as a fitness center, fire pits, meditation gardens, eateries and conference space. Element will anchor 10055 Barnes Canyon R...

Element Biosciences Appoints Mark Aitkenhead, PhD, as Chief Commercial Officer

SAN DIEGO--(BUSINESS WIRE)--Element Biosciences Inc., developer of the Element AVITI™ System, a new and disruptive DNA sequencing platform, today announced the appointment of Mark Aitkenhead, PhD, as Chief Commercial Officer. In this role, Dr. Aitkenhead will build, guide and manage the customer-facing functions of the company, including sales, marketing, customer support and training. As a member of the executive leadership team, he will also develop and implement strategies for driving adopti...
Back to Newsroom